Trial intelligence / Profile preview

Low-Dose Aspirin in Preventing Pre-Eclampsia in Primigravida

NCT07852585Completed

Start
Aug 2025
Primary completion
Jun 2026
Countries
1
01

Overview

Open-label trial of aspirin in preeclampsia (2 arms). Primary endpoints: Incidence of Preeclampsia, Incidence of Placental Abruption and 2 more. Started Aug 2025; status: completed.

02

Drugs

aspirin
03

Conditions

preeclampsia

Beyond the preview

Go deeper on NCT07852585.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07852585.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call